Otsuka Pakistan Limited (PSX:OTSU)
357.91
+11.24 (3.24%)
At close: Nov 28, 2025
Otsuka Pakistan Revenue
Otsuka Pakistan had revenue of 1.08B PKR in the quarter ending September 30, 2025, with 32.70% growth. This brings the company's revenue in the last twelve months to 4.04B, up 27.22% year-over-year. In the fiscal year ending June 30, 2025, Otsuka Pakistan had annual revenue of 3.78B with 19.46% growth.
Revenue (ttm)
4.04B
Revenue Growth
+27.22%
P/S Ratio
1.07
Revenue / Employee
9.91M
Employees
408
Market Cap
4.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.78B | 615.65M | 19.46% |
| Jun 30, 2024 | 3.16B | 128.78M | 4.24% |
| Jun 30, 2023 | 3.04B | 183.35M | 6.43% |
| Jun 30, 2022 | 2.85B | 305.46M | 12.00% |
| Jun 30, 2021 | 2.55B | 319.29M | 14.34% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 74.84B |
| GlaxoSmithKline Pakistan | 62.07B |
| The Searle Company | 30.67B |
| Shifa International Hospitals | 28.52B |
| AGP Limited | 27.73B |
| Highnoon Laboratories | 26.61B |
| Ferozsons Laboratories | 20.27B |
| Citi Pharma | 13.30B |